JP2016193903A5 - - Google Patents

Download PDF

Info

Publication number
JP2016193903A5
JP2016193903A5 JP2016084877A JP2016084877A JP2016193903A5 JP 2016193903 A5 JP2016193903 A5 JP 2016193903A5 JP 2016084877 A JP2016084877 A JP 2016084877A JP 2016084877 A JP2016084877 A JP 2016084877A JP 2016193903 A5 JP2016193903 A5 JP 2016193903A5
Authority
JP
Japan
Prior art keywords
amino
chloro
methyl
combination
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016084877A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016193903A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016193903A publication Critical patent/JP2016193903A/ja
Publication of JP2016193903A5 publication Critical patent/JP2016193903A5/ja
Pending legal-status Critical Current

Links

JP2016084877A 2010-05-26 2016-04-21 組合せ Pending JP2016193903A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34838510P 2010-05-26 2010-05-26
US61/348,385 2010-05-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013512197A Division JP2013526613A (ja) 2010-05-26 2011-05-25 組合せ

Publications (2)

Publication Number Publication Date
JP2016193903A JP2016193903A (ja) 2016-11-17
JP2016193903A5 true JP2016193903A5 (enExample) 2017-01-05

Family

ID=45004353

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013512197A Withdrawn JP2013526613A (ja) 2010-05-26 2011-05-25 組合せ
JP2016084877A Pending JP2016193903A (ja) 2010-05-26 2016-04-21 組合せ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013512197A Withdrawn JP2013526613A (ja) 2010-05-26 2011-05-25 組合せ

Country Status (4)

Country Link
US (2) US20130237554A1 (enExample)
EP (1) EP2575460A4 (enExample)
JP (2) JP2013526613A (enExample)
WO (1) WO2011150044A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013334945A1 (en) * 2012-10-22 2015-04-23 Novartis Ag Combination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005696A (es) * 2000-12-21 2003-10-06 Glaxo Group Ltd Pirimidinaminas como moduladores de angiogenesis.
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
US8592475B2 (en) * 2008-10-16 2013-11-26 Glaxosmithkline Llc Inhibitors of Akt activity
NZ594064A (en) * 2009-01-30 2012-08-31 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride

Similar Documents

Publication Publication Date Title
JP2015083580A5 (enExample)
JP2019131596A5 (enExample)
PH12015502134A1 (en) Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration
CN110036005A (zh) 酰胺衍生物及其在药物中的应用
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
JP2011173928A5 (enExample)
KR20160066554A (ko) 브루톤 타이로신 키나제 억제제 및 면역요법을 이용한 치료
JP2017511360A5 (enExample)
JP2013067645A5 (enExample)
JP2012502015A5 (enExample)
JP2009138003A5 (enExample)
JP2017513809A5 (enExample)
JP2019515908A5 (enExample)
JP2009545600A5 (enExample)
JP2015511635A5 (enExample)
JP2014505107A5 (enExample)
JP2014511383A5 (enExample)
JP2018507243A5 (enExample)
JP2021504384A5 (enExample)
JP2018530578A5 (enExample)
JP2015510916A5 (enExample)
JP2019530706A5 (enExample)
JP2015517523A5 (enExample)
JP2012502103A5 (enExample)
JP2019518022A5 (enExample)